A federal multidistrict litigation currently housing more than 300 GranuFlo lawsuit filings in the District of Massachusetts may soon be adding another case to its list.

According to recent court records, a lawsuit alleging fatal heart injuries on behalf of a patient who died after taking the medication in a Fresenius Medical Care-owned dialysis clinic has been removed to federal court. Among other claims, the case filed in May alleges GranuFlo “was in a dangerous and defective condition at the time of its sale and delivery. Its defective condition presented a danger to its foreseeable users and consumers during ordinary and foreseeable use of the product.”

GranuFlo Fresenius Lawsuit References Fresenius Internal Memo Citing 900 Patient Deaths

GranuFlo lawyers for the plaintiff are also pointing to an internal memo sent by Fresenius to physicians operating in its facilities in November 2011, six months after the patient’s death. The document warned of the dialysis medication’s potential to cause cardiovascular death, sudden cardiac death, heart attacks, and other life-threatening cardiovascular side effects. At the time, company officials said over 900 patients had died after being exposed to GranuFlo or NaturaLyte, which are acid concentrate medications used to neutralize acid that builds up during dialysis treatments. Cardiovascular injuries are experienced within 48 hours after the drug’s administration.

The pending GranuFlo Fresenius lawsuit says Fresenius failed to warn the U.S. Food and Drug Administration (FDA) about its catastrophic heart risks from the time the internal memo was sent until an Urgent Product Notification was issued by the company on March 29th, 2012.

The FDA announced a Class I recall of GranuFlo and NaturaLyte in June 2012.

Now that the case has been removed to federal court, court documents indicate that it may be transferred to the federal GranuFlo lawsuit multidistrict litigation underway in the U.S. District Court, District of Massachusetts. As of July 2013, more than 300 Fresenius GranuFlo lawsuits were pending in the proceeding. On June 21st, a motion to schedule the litigation’s first Case Management Conference and to assign leadership positions to plaintiffs’ attorneys was filed with the Court. (In re: Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428)

Filing a Dialysis Lawsuit

If your loved one experienced fatal or near-fatal catastrophic heart injuries after taking GranuFlo or NaturaLyte during a dialysis treatment, call an attorney at Bernstein Liebhard LLP to learn more about navigating your legal rights. Call the Firm to file a dialysis lawsuit at (877) 779-1414.

Published July 17, 2013 by